Drugs / donor natural killer cell infusion
last change May 2015 re-read 3 minutes ago

donor natural killer cell infusion

Cell therapy

Developed for
acute lymphoblastic leukemia · acute myeloid leukemia
Investigated by
Asan Medical Center · Korea Research Institute of Bioscience & Biotechnology

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01795378 Feb 2013 → May 2015 acute lymphoblastic leukemia, acute myeloid leukemia Asan Medical Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as donor natural killer cell infusion ClinicalTrials.gov intervention name — accepted as the source's own label NCT01795378 ↗
Modality Cell therapy “donor NK cell infusion” NCT01795378 ↗